Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature

por Visser, K, van der Heijde, D
Publicado 2008

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

por Salliot, C, van der Heijde, D
Publicado 2008

Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis

por Lukas, C, Landewé, R, Fatenejad, S, van der Heijde, D
Publicado 2008

Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial

por van der Heijde, D, Landewé, R, van Vollenhoven, R, Fatenejad, S, Klareskog, L
Publicado 2008

Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with...

por Kavanaugh, A, Gladman, D, van der Heijde, D, Purcaru, O, Mease, P
Publicado 2015

Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate

por Kavanaugh, A, Klareskog, L, van der Heijde, D, Li, J, Freundlich, B, Hooper, M
Publicado 2008

Treating rheumatoid arthritis to target: the patient version of the international recommendations

por de Wit, M P T, Smolen, J S, Gossec, L, van der Heijde, D M F M
Publicado 2011

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

por Visvanathan, S, van der Heijde, D, Deodhar, A, Wagner, C, Baker, D G, Han, J, Braun, J
Publicado 2008

Early Disease Activity or Clinical Response as Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis

por van der Heijde, D., Deodhar, A., Fleischmann, R., Mease, P. J., Rudwaleit, M., Nurminen, T., Davies, O.
Publicado 2017

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

por Visvanathan, S, Wagner, C, Marini, J C, Baker, D, Gathany, T, Han, J, van der Heijde, D, Braun, J
Publicado 2008

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blin...

por van der Heijde, D, Fleischmann, R, Wollenhaupt, J, Deodhar, A, Kielar, D, Woltering, F, Stach, C, Hoepken, B, Arledge, T, Mease, P J
Publicado 2014

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

por Rudwaleit, M., Rosenbaum, J. T., Landewé, R., Marzo‐Ortega, H., Sieper, J., van der Heijde, D., Davies, O., Bartz, H., Hoepken, B., Nurminen, T., Deodhar, A.
Publicado 2016

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

por Mease, P J, Fleischmann, R, Deodhar, A A, Wollenhaupt, J, Khraishi, M, Kielar, D, Woltering, F, Stach, C, Hoepken, B, Arledge, T, van der Heijde, D
Publicado 2014

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis

por van der Heijde, D, Pangan, A L, Schiff, M H, Braun, J, Borofsky, M, Torre, J, Davis, J C, Wong, R L, Kupper, H, Collantes, E
Publicado 2008

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

por van der Heijde, D, Schiff, M H, Sieper, J, Kivitz, A J, Wong, R L, Kupper, H, Dijkmans, B A C, Mease, P J, Davis, J C
Publicado 2008

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

por Sieper, J., van der Heijde, D., Dougados, M., Maksymowych, W. P., Scott, B. B., Boice, J. A., Berd, Y., Bergman, G., Curtis, S., Tzontcheva, A., Huyck, S., Weng, H. H.
Publicado 2015

Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial

por Sieper, J, Landewé, R, Rudwaleit, M, van der Heijde, D, Dougados, M, Mease, P J, Braun, J, Deodhar, A, Kivitz, A, Walsh, J, Hoepken, B, Nurminen, T, Maksymowych, W P
Publicado 2015

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

por Braun, J., Haibel, H., de Hooge, M., Landewé, R., Rudwaleit, M., Fox, T., Readie, A., Richards, H. B., Porter, B., Martin, R., Poddubnyy, D., Sieper, J., van der Heijde, D.
Publicado 2019

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists

por Gossec, L, Dougados, M, Phillips, C, Hammoudeh, M, de Vlam, K, Pavelka, K, Pham, T, Braun, J, Sieper, J, Olivieri, I, van der Heijde, D, Collantes, E, Stone, M, Kvien, T K
Publicado 2008

Prevalence and clinical significance of lumbosacral transitional vertebra (LSTV) in a young back pain population with suspected axial spondyloarthritis: results of the SPondyloArth...

por de Bruin, F., ter Horst, S., Bloem, J. L., van den Berg, R., de Hooge, M., van Gaalen, F., Dagfinrud, H., van Oosterhout, M., Landewé, R., van der Heijde, D., Reijnierse, M.
Publicado 2017